Home Noticias de Salud Family Centers Health Centers Resources My Health Manager
  Search
  PersonalMD Services  
  Family Health
  Women's Health
  Children's Health
  Men's Health
  Senior's Health
   
  Health Centers
  Alternative Medicine
  Cardiac Care Center
  Cancer Center
  Emergency Dept
  Medical Advances
  Nutrition Central
  Pulmonary Center
  Sports Medicine
  Travel Medicine
   
  Resources
  Drug Interaction
  Drugs & Medications
  Health Encyclopedia


Back to: Advances in Medicine > Features    
     
 

 

Biologists Discover How Bone And Some Tissue Cells Develop

By NICHOLAS WADE, N.Y. Times

The concept of regenerative medicine -- using the body's own stem cells and growth factors to repair tissues -- has come closer to reality with a discovery about the special human cells from which all bone and connective tissues are derived.

The discovery bolsters the hope that the cells can in principle be used to repair bone, cartilage, tendon and many other injured or aged tissues. The cells would in many cases be derived from the patient's own bone marrow and thus present no problem of immune rejection.

Biologists at Osiris Therapeutics, a privately held biotechnology company in Baltimore, Md., have shown that the cells, called human mesenchymal stem cells, can be converted into bone cells, cartilage cells, fat cells and the stroma cells in the bone marrow that provide support for blood-forming cells.

The company, named after the ancient Egyptian god of regrowth and rejuvenation, also has identified special factors that can be used in the laboratory to drive the cells down each of these distinct lineages. Its work is described in Friday's issue of Science magazine.

Dr. Daniel R. Marshak, Osiris' chief scientific officer, said the mesenchymal stem cells could be formulated so that, when inserted in the right place in the body, they would change into the appropriate tissue.

Tests in animals show that when the cells are grown on ceramic and put into bone, they turn into bone-forming cells. If grown in a gel and inserted into cartilage, they metamorphose into cartilage cells. If injected into the bloodstream, the cells take up residence in the bone and turn into stroma cells.

There is no way of knowing how soon treatments derived from the techniques will be available, but a clinical trial is now under way with breast cancer patients to explore the cells' stroma-forming abilities. Lack of stroma to support blood-forming cells may be why the bone marrow transplants given to cancer patients after chemotherapy are not always successful.

With Novartis AG, the Swiss pharmaceutical company, Osiris also plans to test in humans the cells' abilities to form new bone, tendon and cartilage.

The cells can also be converted to fat cells, which could prove useful in cosmetic surgery and possibly as material for breast implants.


Register About Us Emergency Contact us Privacy Policy Help Center
Resources Health Centers Family Health